NEWTOWN, Pa., July 21, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and ...
VALENCIA, Calif., June 29, 2026 /PRNewswire/ -- Bioness Medical, Inc. ("Bioness", or the "Company"), a global leader in functional electrical stimulation (FES) and advanced rehabilitation technologies ...
Neuvotion, Inc. is an early-stage medical device company developing an AI-guided neuromodulation platform to accelerate ...
Add Yahoo as a preferred source to see more of our stories on Google. A growing number of recovery tools promise better sleep, lower stress, improved focus, and faster recovery. Few have generated as ...
What if chronic diseases, which are difficult to treat with medicine alone, could be managed with electricity? As "neuromodulation"—a technology that restores bodily balance by sending signals ...
Bioness Medical's oral neuromodulation system for rehabilitating stroke patients with gait deficits has secured clearance from the US Food and Drug Administration (FDA). The California-based company's ...
Dublin, Sept. 25, 2019 (GLOBE NEWSWIRE) -- The "Neuromodulation Devices Global Market - Forecast to 2026" report has been added to ResearchAndMarkets.com's offering. Neuromodulation is gaining ...
Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability to ...
In an article published in Brain Medicine, a European research team presents a focused review of emerging neuromodulation techniques for treatment-resistant obsessive-compulsive disorder (OCD). The ...
The FDA authorized marketing of the Portable Neuromodulation Stimulator (Pons) for short-term treatment of gait issues arising from mild to moderate symptoms associated with multiple sclerosis (MS) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results